Monitoring of sleep duration may serve as a useful tool for identifying high-risk people with type 2 diabetes in clinical practice for possible intervention, especially for those being treated with both oral glucose-lowering drugs and insulin. The gene discussed is INS; the disease is type 2 diabetes mellitus.